stockrowInteger Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
- Revenue
- −3.86%
- EPS
- −61.0%
- Free cash flow
- −65.2%
- Total debt
- +4.06%
Quarter to September 2026, against a year earlier
Follow ITGR
Alert me
Integer Holdings Corporation (ITGR) Return on assets
Integer Holdings Corporation's return on assets over the twelve months to 30 September 2026 was 3.05%, down 0.1 percentage points from fiscal 2025 (3.17%). Over the past ten years it has ranged from −0.39% (fiscal 2015) to 6.49% (fiscal 2018); the current reading is higher than 55% of that period. That is above the Medical Devices industry median of −17.3% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 3.17% | (0.81) |
| FY2024 | 3.98% | 0.82 |
| FY2023 | 3.16% | 0.69 |
| FY2022 | 2.47% | (1.44) |
| FY2021 | 3.91% | 0.64 |
| FY2020 | 3.27% | (0.85) |
| FY2019 | 4.12% | (2.37) |
| FY2018 | 6.49% | 4.14 |
| FY2017 | 2.35% | 2.14 |
| FY2016 | 0.21% | 0.60 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| TMDX TransMedics Group, Inc. compare | 11.7% |
| UFPT UFP Technologies, Inc. compare | 11.5% |
| LIVN LivaNova PLC compare | 7.44% |
| HAE Haemonetics Corporation compare | 4.28% |
| ITGR Integer Holdings Corporation | 3.05% |
| NEOG Neogen Corporation compare | −1.68% |
| IRTC iRhythm Holdings, Inc. compare | −3.70% |
| TXG 10x Genomics compare | −7.47% |
| AXGN AxoGen, Inc. compare | −8.33% |
| Medical Devices industry median | −17.3% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on ITGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement